|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
DAESUNG MICROBIOLOGICAL LABS. CO.,LTD.
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name DAESUNG MICROBIOLOGICAL LABS. CO.,LTD. Headquarters 293, SAM-DONG, UIWANG-SI, GYEONGGI-DO; Uiwang; Gyeonggi; 437815 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: SUNJIN (2011) Incorporation Date: February 4, 1966 Total Employees: 127 Tel: 031-461-7103 |
|
Company Description |
| It has a good market position in the animal medicne markets with pig pabosadog vaccine and durable PPS injection. It has shown a sond sales growth despite the animal farming business slowdown as it is operating stably with its market position. The excellent financial stability has been maintained due to the improved management of the sales and administration cost and other costs. The growth will be impaired due to the increased beef meat imported from USA which is damping the domestic animal breeding | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the first half of 2012, total net operating revenues increased with 5.74%, from KRW 9,183,454 thousands to KRW 9,710,734 thousands. Operating result increased from KRW 47,284 thousands to KRW 836,709 thousands which means 1669.54% change. The results of the period increased 507.42% reaching KRW 621,127 thousands at the end of the period against KRW 102,256 thousands last year. Return on equity (Net income/Total equity) went from 0.50% to 3.08%, the Return On Asset (Net income / Total Asset) went from 0.39% to 2.49% and the Net Profit Margin (Net Income/Net Sales) went from 1.11% to 6.40% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 23.82% compared to 30.22% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.01 to 4.15 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 H1 (non-cons) |
2011 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| KR listed company financials | KR listed company financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
24,932,444 |
26,582,985 |
| ||
Current Assets |
9,550,064 |
10,912,916 |
| ||
Total Liabilities |
4,796,146 |
6,753,067 |
| ||
Shareholders Equity |
20,136,298 |
19,829,918 |
| ||
Current Liabilities |
2,298,569 |
3,800,046 |
| ||
| * All the accounts are in KRW. | ||
Income Statement
| ||
Total Operating Revenue |
9,710,734 |
17,148,022 |
| ||
Operational Profit (Loss) |
836,709 |
-813,680 |
| ||
Net Profit (Loss) |
621,127 |
-307,780 |
| ||
| * All the accounts are in KRW. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
2.49% |
-1.16% |
| ||
Return on Equity (ROE) |
3.08% |
-1.55% |
| ||
Return on Sales (ROS) |
6.4% |
-1.79% |
| ||
Return on Capital |
2.74% |
-1.35% |
| ||
Gross Profit Margin |
29.42% |
20.86% |
| Efficiency Ratios | ||
| ||
Current asset turnover |
1.02x |
1.57x |
| ||
Asset Turnover |
0.39x |
0.65x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
323,464 |
-276,917 |
| ||
EBITDA |
897,362 |
-677,493 |
| ||
Bookvalue (BV) |
19,404,369 |
19,037,335 |
| Liquidity Ratios | ||
| ||
Current Ratio |
415.48% |
287.18% |
| ||
Quick ratio |
224.89% |
163% |
| ||
Doom's day ratio |
34.22% |
15.99% |
| ||
Cash Flow to Debt |
3.76% |
-9.38% |
| Leverage Ratios | ||
| ||
Leverage ratio |
123.82% |
134.05% |
| ||
Interest Coverage Ratio |
719.64% |
-234.11% |
| ||
Debt to equity |
23.82% |
34.05% |
| ||
Debt to total assets |
19.24% |
25.4% |
| ||
Long Term Debt to Capital |
11.03% |
12.96% |
| Market ratios | ||
| ||
Price/Book Ratio |
0.67 |
0.64 |
| Trend Ratios | ||
| ||
Revenue Trend |
105.74% |
97.76% |
| ||
Net Income Trend |
607.42% |
-45.73% |
| ||
 |